Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
10.1016/S0140-6736(19)31271-1 Summary Keywords colorectal cancer, gastrointestinal cancer, GLP-1 receptor agonists, liver cancer, meta-analysis, obesity, oncological safety, pancreatic cancer Citation Wali AF, Rangraze I, Khan S, Mufti UB, El-Tanani M and Rizzo M (2026) Reassessing cancer risk with GLP-1 receptor agonists: a comprehensive meta-analysis of gastrointestinal malignancies
therefore, drugs targeting EPHB1, PI3K/AKT, and Bcl-2/Bcl-xL, which are involved in the apoptosis resistance pathway, have been developed 28
Turan I, Sayan Ozacmak H, Ozacmak VH, Ergenc M, Bayraktarolu T
Our team can help verify insurance benefits and discuss self-pay alternatives
While it has many benefits, some people report experiencing heart palpitations while using it
US$ 26.85
US$ 23.12
US$ 25.58
